Login to Your Account

U.S. Patent Disclosures

Wednesday, January 4, 2012
• Rexahn Pharmaceuticals Inc., of Rockville, Md., received U.S. Patent No. 8,034,829, titled "5, 6, or 7-Substituted-3-(hetero) arylisoquinolinamine derivatives and therapeutic use therof." It covers several new isoquinolinamine compounds and their pharmaceutical composition and method for producing an antitumor effect.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription